Desonide Patent Expiration

Desonide is Used for treating mild to moderate atopic dermatitis in patients 3 months of age and older. It was first introduced by Padagis Us Llc in its drug Desonide on Approved Prior to Jan 1, 1982. Other drugs containing Desonide are Desowen, Verdeso, Desonate. 15 different companies have introduced drugs containing Desonide.


Desonide Patents

Given below is the list of patents protecting Desonide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Verdeso US8460641 Microemulsion process and composition Aug 13, 2027 Almirall
Verdeso US8962000 Microemulsion and sub-micron emulsion process and compositions Aug 31, 2025 Almirall
Verdeso US9492384 Microemulsion and sub-micron emulsion process and compositions Aug 31, 2025 Almirall
Desonate US6387383 Topical low-viscosity gel composition Aug 03, 2020

(Expired)

Leo Pharma As
Verdeso US6730288 Mousse composition Sep 08, 2019

(Expired)

Almirall
Verdeso US7029659 Mousse composition Sep 08, 2019

(Expired)

Almirall



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Desonide's patents.

Given below is the list recent legal activities going on the following patents of Desonide.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 18 Apr, 2024 US9492384
Payment of Maintenance Fee, 4th Year, Large Entity 15 Apr, 2020 US9492384
Patent Issue Date Used in PTA Calculation 15 Nov, 2016 US9492384
Recordation of Patent Grant Mailed 15 Nov, 2016 US9492384
Email Notification 27 Oct, 2016 US9492384
Issue Notification Mailed 26 Oct, 2016 US9492384
Dispatch to FDC 17 Oct, 2016 US9492384
Application Is Considered Ready for Issue 14 Oct, 2016 US9492384
Issue Fee Payment Received 13 Oct, 2016 US9492384
Issue Fee Payment Verified 13 Oct, 2016 US9492384


Desonide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Desonide Generics

Several generic applications have been filed for Desonide. The first generic version for Desonide was by Galderma Laboratories Lp and was approved on Jun 15, 1988. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Dec 8, 2022.

Given below is the list of companies who have filed for Desonide generic.


1. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% cream Prescription TOPICAL AB Dec 8, 2022


2. CADILA

Cadila Healthcare Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cadila.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% cream Prescription TOPICAL AB Nov 20, 2019


3. CINTEX SVCS

Cintex Services Llc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cintex Svcs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05%

(reference standard)

gel Prescription TOPICAL N/A May 11, 2020


4. COSETTE

Cosette Pharmaceuticals Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% cream Prescription TOPICAL AB Sep 28, 1992


5. ENCUBE ETHICALS

Encube Ethicals Pvt Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Encube Ethicals.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% ointment Prescription TOPICAL AB Jan 30, 2019


6. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% lotion Prescription TOPICAL AB Mar 19, 2002


7. GALDERMA LABS LP

Galderma Laboratories Lp has filed for 1 generic for Desonide. This 0.05% version comes by the name DESOWEN. Given below are the details of the strengths of this generic introduced by Galderma Labs Lp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05%

(reference standard)

lotion Prescription TOPICAL AB Jan 24, 1992


8. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% ointment Prescription TOPICAL AB Sep 15, 2017


9. GLENMARK SPECLT

Glenmark Specialty Sa has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% lotion Prescription TOPICAL AB Sep 26, 2017


10. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% ointment Discontinued TOPICAL N/A Mar 27, 2017


11. PAI HOLDINGS PHARM

Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% ointment Discontinued TOPICAL N/A Mar 12, 2019


12. TARO

Taro Pharmaceutical Industries Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% lotion Prescription TOPICAL AB Oct 31, 2014